Penile prosthesis extrusion due to gonococcal infection

Gonococcal infection of a penile prosthesis is a rare presentation of a common disease. Here we report two cases of penile prosthesis extrusion due to gonococcal infection.     

Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan

This retrospective study reports on the treatment outcomes of 45 men with penile cancer and seeks to address the issue concerning the treatment of inguinal lymph nodes (LN). Of these 45 patients, five had verrucous carcinoma and the other 40 had squamous cell carcinoma. Eighteen patients had inguinal lymph nodes (LNs) metastasis and received treatments of inguinal LNs involving bilateral inguinal LN dissection or unilateral inguinal LN dissection with or without postoperative radiotherapy. The median follow-up was 37 months. The ultimate local and regional controls for patients with verrucous carcinoma were 100 and 100%, respectively. Among the 40 patients with squamous cell carcinoma, the overall local control rate was 90%. The 5-year overall survival (OS) and disease-free survival (DFS) rates of patients without or with pathological inguinal LN metastasis were 70 vs. 22% (p=0.01), and 55 vs. 16% (p=0.004), respectively. The regional failure rates after inguinal LN dissection for pathological inguinal LN metastasis were 11% (1/9) and 60% (3/5) in patients with and without adjuvant radiotherapy. This study demonstrates that verrucous carcinoma shows excellent treatment outcomes following surgery alone. Squamous cell carcinoma of the penis is associated with a high incidence of inguinal lymph node metastasis. Elective groin dissection is indicated for all penile cancer patients except those with verrucous carcinoma and pT1 cancer with well-differentiated tumor. For patients with pathologically positive inguinal LN metastasis, adjuvant radiotherapy can increase inguinal control in this study. It warrants further prospective trial to prove the value of adjuvant radiotherapy in patients with pathological documented inguinal LN metastasis in penile cancer.     

Male tolerance study of 1% C31G

BACKGROUND: C31G is being studied as a vaginal contraceptive and microbicide. This study was conducted to ensure that male partners of the women in future trials of C31G will not be subjected to an undue risk of penile irritation. METHODS: This was a randomized, double-blinded, single-center Phase I study in circumcised and uncircumcised men to assess penile irritation, safety and acceptability of seven consecutive daily doses of 1.0% C31G compared with a marketed spermicide, Extra Strength Gynol II(R) (3% nonoxynol-9) (ES Gynol II). Each participant was instructed to apply the study product to his penis at bedtime, to wash it off 6-10 h later, and to record any symptoms on a diary card. At the follow-up visit, a genital examination was performed and participants were again asked about adverse events and to complete an acceptability questionnaire. RESULTS: Of the 36 men enrolled, 12.5% of C31G users and 16.7% of Extra Strength Gynol II users reported product-related adverse events (AEs). All product-related AEs were considered mild by the investigator, except for one in the ES Gynol II group. Both products were acceptable. CONCLUSION: The manner in which the products were used in this study is not the route by which men will be exposed to such products in actual use, and results should be considered in this light. Based on the observations in this study, C31G appears to be at least as safe and acceptable for male penile exposure as the marketed product ES Gynol II.     

Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer

PURPOSE/OBJECTIVE: In this study, we evaluated in a serial manner whether radiation dose to the bulb of the penis is predictive of erectile dysfunction, ejaculatory difficulty (EJ), and overall satisfaction with sex life (quality of life) by using serial validated self-administered questionnaires. METHODS AND MATERIALS: Twenty-nine potent men with AJCC Stage II prostate cancer treated with three-dimensional conformal radiation therapy alone to a median dose 72.0 Gy (range: 66.6-79.2 Gy) were evaluated by determining the doses received by the penile bulb. The penile bulb was delineated volumetrically, and the dose-volume histogram was obtained on each patient. RESULTS: The median follow-up time was 35 months (range, 16-43 months). We found that for D(30), D(45), D(60), and D(75) (doses to a percent volume of PB: 30%, 45%, 60%, and 75%), higher than the corresponding median dose (defined as high-dose group) correlated with an increased risk of impotence (erectile dysfunction firmness score = 0) (odds ratio [OR] = 7.5, p = 0.02; OR = 7.5, p = 0.02; OR = 8.6, p = 0.008; and OR = 6.9, p = 0.015, respectively). Similarly, for EJD D(30), D(45), D(60), and D(75), doses higher than the corresponding median ones correlated with worsening ejaculatory function score (EJ = 0 or 1) (OR = 8, p = 0.013; OR = 8, p = 0.013; OR = 9.2, p = 0.015; and OR = 8, p = 0.026, respectively). For quality of life, low (< or =median dose) dose groups of patients improve over time, whereas high-dose groups of patients worsen. CONCLUSIONS: This study supports the existence of a penile bulb dose-volume relationship underlying the development of radiation-induced erectile dysfunction. Our data may guide the use of inverse treatment planning to maximize the probability of maintaining sexual potency after radiation therapy.     

Operative Therapie der erektilen Dysfunktion

Zusammenfassung Mit dieser Arbeit soll im Zeitalter der Dominanz der oralen Pharmakotherapie bei der Behandlung erektiler Funktionsstörungen eine kritische Übersicht über den aktuellen Stellenwert der operativen Therapie der erektilen Dysfunktion gegeben werden. Als mögliche Therapieoptionen werden die penile Venenchirurgie, die arterielle Revaskularisationschirurgie und die penile Prothesenchirurgie beurteilt.Die Venenchirurgie hat heute aufgrund der Wirksamkeit der oralen und intrakavernösen Therapeutika, bedingt durch den Pathomechanismus der kavernovenösen Insuffizienz und durch die publizierten enttäuschenden Langzeitergebnisse ihren Stellenwert gänzlich verloren. Ähnlich verhält es sich mit den penilen Revaskularisationsoperationen, die heutzutage nur noch bei einem hochselektioniertem Patientengut ihre Berechtigung hat. Wichtige Selektionskriterien sind Patientenalter und Ausschluss eines Diabetes mellitus.Einzig die penile Prothesenchirurgie behauptet gegenüber der medikamentösen Therapie der Erektionsstörungen ihren Stellenwert. Hier überzeugen die guten Langzeitergebnisse, die hohe Patienten- und Partnerinnenzufriedenheit bzw. -akzeptanz und die funktionelle Haltbarkeit der in ihrer Mehrzahl dreiteilig, hydraulischen Implantate.

---

     

Dopamine D1 receptor agonists induce penile erections in rats

The dopamine receptor agonist apomorphine has been recently introduced in the treatment of erectile dysfunction. While it is well established that dopamine D2-like receptors play a crucial role in this effect, conflicting result are reported in the literature as for the role of dopamine D1-like receptors. The aim of this study was to determine the effect of systemic administration of dopamine D1-like receptor agonists on penile erection in rats. Male Wistar rats were treated with three different, and not structurally related, dopamine D1-like receptor agonists: the partial agonists SKF38393 ((+) 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine) and CY 208-243 ((-)-4,6,6a,7,8,12b-exahydro-7-methylindole [4,3-ab]fenantridine), and the full agonist A 77636 ((-)-(1R,3S)-3-Adamantyl-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyran hydrochloride). All three compounds dose-dependently increased the number of penile erections, with the full agonist A77636 showing a more pronounced effect with respect to the other two. Moreover, the dopamine D1-like receptor antagonist SCH 23390 ((R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) dose-dependently antagonised A77636 effect. These results show that systemic administration of dopamine D1-like receptor agonists induce penile erection in rats. This observation suggests that dopamine D1-like receptor agonists might be considered as a possible alternative to apomorphine in the treatment of erectile dysfunction, thus avoiding the typical side effects related to the stimulation of dopamine D2-like receptors such as nausea.     

阴囊皮瓣在阴茎创面修复中的运用

目的探讨阴囊皮瓣在阴茎创面修复中的作用。方法采用阴囊任意皮瓣修复皮肤软组织缺损21例,清洁创面采取一期修复,污染创面彻底清创后修复,感染创面待感染控制、坏死组织完全脱落后二期修复,供瓣区均直接缝合。结果1例因排尿困难发生伤口裂开,其余20例皮瓣全部成活,切口一期愈合。术后随访6个月~6年,皮瓣修复的创面局部弹性良好,无1例发生勃起功能及排尿功能障碍,远期效果较好。结论阴囊皮肤血供丰富,伸展性好,阴囊任意皮瓣长:宽达3:1仍能较好存活。可修复阴茎任意部位创面,供瓣区一般能直接缝合,术后阴茎阴囊功能均未受较大影响,是简单易行、安全有效的阴茎创面修复的方法之一。     

Sonographic measurement of penile erectile volume.

For more accurate determination of the penile erectile volume in the flaccid and erectile states, and the difference between them, 20 impotent patients from 36 years old to 70 years old were enrolled in the study. Penile Doppler ultrasonography was performed to check the diameter of each corpus cavernosum, and diameter and peak flow velocity of each cavernous artery before and after intracavernous injection with 10 micrograms to 20 micrograms prostaglandin E1 (PGE1). The penile length was measured from base to midglans manually before and after PGE1 injection. The erectile volume in flaccid and erectile states was calculated as pi r2 x length. The summation of erectile volume of left and right corpus cavernosum was taken as the total erectile volume. The patients were classified into good (10 patients) and poor (10 patients) response groups based mainly on the mean peak flow velocity of both cavernous arteries greater or less than 25 cm/s. There was a significant increase of erectile parameters (penile length, diameter of corpus cavernosum, and total erectile volume) after PGE1 injection in each group of patients. For the total of 20 patients, the mean increase of penile length was 4.27 cm (80.0%), the diameter of corpus cavernosum was 0.66 cm (77.9%), and total erectile volume was 27.87 mL (459.0%). A comparison of the increase of penile erectile parameters after PGE1 injection between the good and poor response groups of patients revealed a significantly greater increase of the diameter of corpus cavernosum in the good response patients.     

新生儿阴茎长度及其相关因素的探讨

本文测定了208名生后5天内的新生儿阴茎长度,并对新生儿阴茎长度与胎龄、出生体重、出生身长的关系进行了探讨。结果为(1)成熟儿阴茎长度平均值±1SD为33.8±3.7mm,正常范围为26.4～41.2mm(平均值±2SD);(2)适于胎龄儿和小于胎龄儿阴茎长度与胎龄、出生体重、出生身长呈明显正相关;(3)大于胎龄儿阴茎长度平均值±1SD为34.6±3.2mm,正常范围与成熟儿相同。新生儿阴茎正常值的确定有助于小阴茎畸形的诊断和疗效的判断。